https://www.selleckchem.com/pr....oducts/pifithrin-alp
Among 478 patients with CES, the median hs-CRP level was 6.09 mg/L. Regarding the primary outcome, we found that hs-CRP levels ≥22.30 mg/L were positively correlated with poor outcomes at the 3-month and 1-year follow-ups [odds ratio (OR) 3.862, 95% confidence interval (CI) (1.675-8.904), P=0.002; and OR 5.479, 95% CI (1.692-17.744), P=0.005, respectively]. The secondary outcomes paralleled the results of the primary outcomes at the 3-month and 1-year follow-ups [OR 3.381, 95% CI (1.620-7.058), P=0.001; and OR 3.181, 95% CI (1.4
Like
Comment
Share
